Screening for Alzheimer's drugs in tandem
28 June 2011
A simple assay based on sequential enzymatic reactions and a fluorescent sensor could help scientists to discover new Alzheimer's disease drugs.
Some Alzheimer's drugs work by blocking the activity of acetylcholinesterase, an enzyme that degrades the neurotransmitter acetylcholine to choline. To find new enzyme inhibitors, researchers need to identify choline formation, or the loss of acetylcholine, so they can tell whether the enzymatic reaction has stopped. But, acetylcholine and choline are both quaternary ammonium ions with very similar structures, making it difficult to distinguish between them.
To overcome this problem, teams led by Werner Nau at Jacobs University Bremen, Germany, and Yu Liu at Nankai University, China, have combined two sequential enzymatic reactions with a calixarene macrocycle that binds to a fluorescent dye to make a tandem assay that can screen for new inhibitors. The enzymes are highly specific and only work on one substrate.
The tandem reaction involves a fluorescence ''switch-on'' displacement assay as a sensor for specific analytes
In their assay, they use acetylcholinesterase to turn acetylcholine to choline. A second enzyme - choline oxidase - turns the choline into betaine. While choline and betaine are similar, they have different affinities for binding within the calixarene. Because of this difference, the dye can replace the betaine inside the calixarene. This turns off the dye's fluorescence, which is easy to detect. If the enzymatic reactions are inhibited, no betaine will be produced and so the dye's fluorescence stays on.
Pablo Ballester, an expert in supramolecular chemistry at the Institute of Chemical Research of Catalonia, Spain, welcomes the research. He says it 'represents a clever implementation of the use of enzymes to overcome the reduced binding selectivity exhibited by the negatively charged synthetic receptors of the calixarene family in the recognition of quaternary ammonium ions.'
Nau's team demonstrated their assay with acetylcholinesterase and choline oxidase but the principle could be adapted to other enzymatic reactions. In the future, Nau hopes to 'set up a large library of calixarene and dye pairs that are useful for a large range of analytes and biochemical reactions.'
Interesting? Spread the word using the 'tools' menu on the left.
Link to journal article
Operational calixarene-based fluorescent sensing systems for choline and acetylcholine and their application to enzymatic reactions
Dong-Sheng Guo, Vanya D. Uzunova, Xin Su, Yu Liu and Werner M. Nau, Chem. Sci., 2011, 2, 1722
Also of interest
04 March 2011
Scientists can now monitor the formation of the earliest aggregates in a peptide linked to Alzheimer's disease
06 August 2009
Cures for Alzheimer's may come from understanding its chemistry. Arvi Rauk examines the disease at the molecular level
23 March 2010
For many years, beta amyloid has been blamed for causing Alzheimer's - but could it also be protecting us from infection?
Comment on this story at the Chemistry World blog
Read other posts and join in the discussion
External links will open in a new browser window